Clinical Trials Browser

Active not recruiting × Ovarian Clear Cell Carcinoma × lenvatinib × Clear all

NCT05296512 2025-12-16

Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer

Phase 2 Active not recruiting

Ovarian Clear Cell Carcinoma